Exposure to antiretroviral therapy in utero or early life: The health of uninfected children born to HIV-infected women

Journal of Acquired Immune Deficiency Syndromes

Volumn 32, Issue 4, 2003, Pages 380-387

  Newell, M L ^a   Giaquinto, C ^a,b   Ruga, E ^a,b   De Rossi, A ^a,b   Grosch Worner I ^a,c   Mok, J ^a,d   Johnstone, F ^a,e   De Jose I ^a,f   Bates, I ^a,f   Salas, S ^a,f   Ladron de Guevara C ^a,f   Pena J M ^a,f   Gonzalez Garcia, J ^a,f   Arribas Lopez, J R ^a,f   Garcia Rodriguez, M C ^a,f   Asensi Botet, F ^a,g   Otero, M C ^a,g   Perez Tamarit D ^a,g   Ridaura, S ^a,g   Gregori, P ^a,g   De la Torre, R ^a,g   Scherpbier, H ^a,h   Kreyenbroek, M ^a,h   Boer, K ^a,h   Bohlin, A B ^a,i   Lindgren, S ^a,i   Ehrnst, A ^a,i   Belfrage, E ^a,i   Naver L ^a,i   Levy, J ^a,j   Barlow, P ^a,j   Hainaut, M ^a,j   Peltier, A ^a,j   Wibaut, S ^a,j   Ferrazin, A ^a,k   Bassetti, D ^a,k   De Maria, A ^a,l   Gotta, C ^a,k   Mur A ^a,m   Paya A ^a,m   Vinolas M ^a,m   Lopez Vilchez M A ^a,m   Rovira, M A ^a,m   Carreras, R ^a,m   Valerius, N H ^a,n   Coll, O ^a,o   Vidal, R ^a,o   Perez J M ^a,o   Boguna J ^a,p   Fortuny, C ^a,p   Pardi, G ^a,q   Ravizza, M ^a,q   Guerra, B ^a,r   Lanari, M ^a,r   Bianchi, S ^a,r   Bovicelli, L ^a,r   Savasi, V ^a,s   Vigano A ^a,s   Ferrazzi, E ^a,s   Brambilla, T ^a,s   Bianchi, L ^a,s   Maccabruni, A ^a,t   Taylor, G P ^a,u   Lyall, E G H ^a,u   Penn, Z ^a,v   Buffolano, W ^a,w   Martinelli, P ^a,w   Sansone, M ^a,w   Tibaldi, C ^a,x   Marini, C ^a,x   Masuelli, G ^a,x   Benedetto, C ^a,x   Niemiec T ^a,y   Marczynska, M ^a,y   more..

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF PADOVA   (Italy)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f HOSPITAL INFANTIL LA PAZ   (Spain)

^g HOSPITAL UNIVERSITARIO LA FE   (Spain)

^h ACADEMIC MEDICAL CENTER   (Netherlands)

ⁱ KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^j SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^k UNIVERSITY OF GENOA   (Italy)

^l UNIVERSITY OF GENOA   (Italy)

^m UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

ⁿ HVIDOVRE HOSPITAL   (Denmark)

^o HOSPITAL CLÍNIC   (Spain)

^p HOSPITAL SANT JOAN DE DÉU   (Spain)

^q Azienda Ospedaliera San Paolo   (Italy)

^r UNIVERSITY OF BOLOGNA   (Italy)

^s UNIVERSITY OF MILAN   (Italy)

^t FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^u ST MARY S HOSPITAL   (United Kingdom)

^v CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^w UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^x UNIVERSITY OF TURIN   (Italy)

^y SP ZOZ Wojewodzki Szpital Zakazny Centrum Diagnostyki i Terapii AIDS Warszawa   (Poland)

more..

Author keywords

Abnormalities; Antiretroviral therapy; Europe; HIV; Uninfected children

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR;

ADOLESCENT; ADULT; ANEMIA; ARTICLE; CHILD; CHILD HEALTH CARE; CONGENITAL DISORDER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE TRANSMISSION; DOWN SYNDROME; FEMALE; FOLLOW UP; HEALTH STATUS; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDRONEPHROSIS; INFANT; KIDNEY POLYCYSTIC DISEASE; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MITOCHONDRION; NEWBORN; NEWBORN CARE; POLYDACTYLY; PREMATURITY; PRENATAL CARE; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROPHYLAXIS; THROMBOCYTOPENIC PURPURA; VERTICAL TRANSMISSION;

EID: 0037379462     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200304010-00006     Document Type: Article

References (31)

1. European Collaborative Study and the Swiss Mother + Child HIV Cohort Study. Combination antiretroviral therapy and duration of pregnancy. AIDS 2000;14:2913-20.
2. Blanche S, Tardieu M, Rustin P, et al. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet 1999;354:1084-9.
3. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994;331:1173-80.
4. Sperling RS, Shapiro DE, McSherry GD, et al. Safety of the maternal-infant zidovudine regimen used in the Pediatric AIDS Clinical Trial Group 076 study. AIDS 1998;12:1805-13.
5. Lorenzi P, Spicher VM, Laubereau B, et al. Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. AIDS 1998; 12(Suppl):F241-7.
6. Fundaro C, Genovese O, Rendeli C, et al. Myelomeningocele in a child with intrauterine exposure to efavirenz. AIDS 2002;16:299-300.
7. French Perinatal Cohort Study Group. Risk of early febrile seizure with perinatal exposure to nucleoside analogues. Lancet 2002;359:583-4.
8. Mandelbrot L, Landreau-Mascaro A, Rekacewicz C, et al. Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1. JAMA 2001;285:2083-93.
9. European Collaborative Study. HIV-infected pregnant women and vertical transmission in Europe since 1986. AIDS 2001;15:761-70.
10. European Collaborative Study. Maternal viral load and vertical transmission of HIV-1: an important factor but not the only one. AIDS 1999;13:1377-85.
11. Dominguez K, Bertolli J, Fowler M, et al. Lack of definitive severe mitochondrial signs and symptoms among deceased HIV-uninfected and HIV-indeterminate children ≤5 years of age: Pediatric Spectrum of HIV Disease project (PSD), USA. Ann NY Acad Sci 2000;918:236-46.
12. Bulterys M, Nesheim S, Abrams EJ, et al. Lack of evidence of mitochondrial dysfunction in the offspring of HIV-infected women: retrospective review of perinatal exposure to antiretroviral drugs in the perinatal AIDS collaborative transmission study. Ann NY Acad Sci 2000;918:212-21.
13. Grosch-Worner I, Schafer A, Obladen M, et al. An effective and safe protocol involving zidovudine and caesarean section to reduce vertical transmission of HIV-1 infection. AIDS 2000;14:2903-11.
14. Hanson IC, Antonelli A, Sperling RS, et al. Lack of tumors in infants with perinatal HIV-1 exposure and fetal/neonatal exposure to zidovudine. J Acquir Immune Defic Syndr 1999;20:463-7.
15. Culnane M, Fowler MG, Lee SS, et al. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. JAMA 1999;281:151-7.
16. De Santis M, Carducci B, De Santis L, et al. Periconceptional exposure to efavirenz and neural tube defects. Arch Intern Med 2002;162:355.
17. Richardson MP, Osrin D, Donaghy S, et al. Spinal malformations in the fetuses of HIV infected women receiving combination antiretroviral therapy and co-trimoxazole. Eur J Obstet Gynecol Reprod Biol 2000;93:215-7.
18. Jungmann EM, Mercey D, DeRuiter A, et al. Is first trimester exposure to the combination of antiretroviral therapy and folate antagonists a risk factor for congenital abnormalities? Sex Transm Inf 2001;77:441-3.
19. Lipschultz SE, Easley KA, Orav EJ, et al. Absence of cardiac toxicity of zidovudine in infants. N Engl J Med 2000;343:759-66.
20. White A, Eldridge R, Andrews E, et al. Birth outcomes following zidovudine exposure in pregnant women: the Antiretroviral Pregnancy Registry. Acta Paediatr Suppl 1997;421:86-8.
21. Tuomala R, Shapiro DE, Mofenson L, et al. Antiretroviral therapy during pregnancy and the risk of an adverse outcome. N Engl J Med 2002;346:1863-70.
22. Thorne C, Fiore S, Newell ML. HIV infected women: does use of antenatal antiretroviral therapy increase risk of premature delivery? July 1, 2002. Available at: http://www.Eurosurveillance.org. Accessed July 24, 2002.
23. Mauri A, Piccione E, Deiana P, et al. Obstetric and perinatal outcome in human immunodeficiency virus-infected pregnant women with and without opiate addiction. Eur J Obstet Gynecol Reprod Biol 1995;58:135-40.
24. Chotpitayasunondh T, Vanprapar N, Simonds RJ, et al. Safety of late in utero exposure to zidovudine in infants born to human immunodeficiency virus-infected mothers: Bangkok. Pediatrics 2001;107:E5.
25. Hatch EE, Palmer JR, Titus-Ernstoff L, et al. Cancer risk in women exposed to diethylstilbestrol in utero. JAMA 2002;280:630-4.
26. National Cancer Institute. DES: questions and answers. May 9, 2002. Available at: http://cis.nci.nih.gov/fact/3_4.htm. Accessed June 11, 2002.
27. Ewings EL, Gerschenson M, St. Claire MC, et al. Genotoxic and functional consequences of transplacental zidovudine exposure in fetal monkey brain mitochondria. J Acquir Immune Defic Syndr 2000;24:100-5.
28. Olivero OA, Fernandez JJ, Antiochos BB, et al. Transplacental genotoxicity in combined antiretroviral nucleoside therapy in Erythrocebus patas monkeys. J Acquir Immune Defic Syndr 2002; 29:323-9.
29. Perinatal Safety Review Working Group. Nucleoside exposure in the children of HIV-infected women receiving antiretroviral drugs: absence of clear evidence for mitochondrial disease in children who died before 5 years of age in five United States cohorts. J Acquir Immune Defic Syndr 2000;25:261-8.
30. World Health Organisation. WHO mortality database. 1997-1999 world health statistics annual. Available at: http://www3.who. ch/whosis/whsa/whsa_table2. Accessed May 14, 2002.
31. Pregnancy and HIV infection: a European consensus on management. AIDS 2002;16(Suppl 2):1-24.